Assessing GeneDx Holdings (WGS) Valuation After Recent Share Price Weakness [Yahoo! Finance]
GeneDx Holdings Corp. - Class A (WGS)
Company Research
Source: Yahoo! Finance
Why GeneDx Holdings is on investors' radar GeneDx Holdings (WGS) has attracted attention after a period of weak share performance, including a negative return over the past month and past 3 months. This has prompted closer scrutiny of its genomics focused business and financial profile. See our latest analysis for GeneDx Holdings. At a latest share price of US$57.09, GeneDx Holdings has seen sharp recent weakness, with a 30 day share price return of 28.38% decline and year to date share price return of 56.85% decline. This is set against a three year total shareholder return that is several times higher than the starting point, which may suggest that momentum has recently faded following a very strong earlier run. If this kind of volatility has your attention, it can help to compare GeneDx with other healthcare focused AI names using a dedicated stock screener for fresh ideas in the same theme, starting with 34 healthcare AI stocks With GeneDx trading at US$57.09 and an ind
Show less
Read more
Impact Snapshot
Event Time:
WGS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WGS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WGS alerts
High impacting GeneDx Holdings Corp. - Class A news events
Weekly update
A roundup of the hottest topics
WGS
News
- GeneDx (WGS) had its price target lowered by Guggenheim from $170.00 to $100.00. They now have a "buy" rating on the stock.MarketBeat
- Is GeneDx Holdings (WGS) Pricing In Its Sharp 27% Weekly Share Price Move? [Yahoo! Finance]Yahoo! Finance
- GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type CBusiness Wire
- A Look At GeneDx Holdings (WGS) Valuation After Strong Earnings And Genomics AI Developments [Yahoo! Finance]Yahoo! Finance
- Wall Street Analysts Believe GENEDX HOLDINGS (WGS) Could Rally 77.81%: Here's is How to Trade [Yahoo! Finance]Yahoo! Finance
WGS
Earnings
- 2/23/26 - Beat
WGS
Sec Filings
- 3/30/26 - Form 4
- 3/30/26 - Form 4
- 3/17/26 - Form 4
- WGS's page on the SEC website